Clinical Trials Browser

Phase 2/3 × OTHER × Mastocytosis × Clear all

NCT01481909 2016-11-03

SMART

Phase 2/3 Completed

Mastocytosis

NCT01602939 2016-08-29

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis

Phase 2/3 Unknown

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

NCT01333293 2016-01-18

XOLMA

Phase 2/3 Completed

Mastocytosis